Recently, chitinases CHIT1, CHI3L1, and CHI3L2 have emerged as potential CSF and blood biomarkers for ALS, as their expression is associated with neuroinflammation [19], with elevated CSF chitinase levels observed in ALS patients compared to controls and ALS mimics [20]. Here, CHI3L2 is linked to amyotrophic lateral sclerosis.